BlackRock Investment Management, LLC - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 12 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,000
-50.0%
3,2450.0%0.00%
Q4 2015$2,000
-50.0%
3,2450.0%0.00%
Q3 2015$4,000
-33.3%
3,2450.0%0.00%
Q2 2015$6,0003,2450.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Geduld E E 35,000$66,0000.04%
Ifrah Financial Services, Inc. 20,956$40,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$25,0000.01%
Pine River Capital Management L.P. 250,000$286,0000.00%
Spark Investment Management LLC 13,500$25,0000.00%
A.R.T. Advisors, LLC 10,201$19,0000.00%
CITIGROUP INC 346$1,0000.00%
GOLDMAN SACHS GROUP INC 32,745$62,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,000$38,0000.00%
MORGAN STANLEY 126$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders